Philip D. Hansten - Concepedia

Author

Philip D. Hansten

Also Known As

P D Hansten, P Hansten, P. D. HANSTEN, P. D. Hansten, P. Hansten, P.D. Hansten, PHILIP D. HANSTEN, Philip D Hansten, Philip D. Hansten, Philip Hansten

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Washington University of Arizona University of Pittsburgh Fred Hutch Cancer Center Albert Einstein College of Medicine

About

Philip D. Hansten is an author at University of Washington specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	2K
2	Public Health	2	2	430
3	Biochemistry	2	2	51
4	Natural Sciences	1	1	14
5	Anatomy	1	1	36

Philip D. Hansten

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Proposal for a New Tool to Evaluate Drug Interaction Cases John R. Horn, Philip D. Hansten, Lingtak‐Neander Chan Annals of Pharmacotherapy New ToolDrug Interaction CausationPharmacotherapyDrug ClassAdverse Drug Reaction	2007	566
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Diana C. Farrow, Thomas L. Vaughan, Philip D. Hansten, PubMed Anti-inflammatoryAnti-inflammatory AgentsOncologyHealth PolicyGastrointestinal Oncology	1998	417
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Diana C. Farrow, Thomas L. Vaughan, Carol Sweeney, Cancer Causes & Control	2000	228
Concordance of Severity Ratings Provided in Four Drug Interaction Compendia Jacob Abarca, Daniel C. Malone, Edward P. Armstrong, Journal of the American Pharmacists Association Drug SafetyDrug InteractionsSubstance AbusePsychiatryAddiction	2004	207
Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions Daniel C. Malone, Edward P. Armstrong, Jacob Abarca, Journal of the American Pharmacists Association Drug InteractionsSubstance AbusePrevent Drug–drug InteractionsDrug IntelligencePharmacology	2004	189
Statin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic Study Ilir Agalliu, Claudia A. Salinas, Philip D. Hansten, American Journal of Epidemiology	2008	159
Performance of Community Pharmacy Drug Interaction Software Thomas K. Hazlet, Todd A. Lee, Philip D. Hansten, Journal of the American Pharmaceutical Association (1996) Drug InteractionsDrug Information SystemPharmacologyPharmacotherapyMedicine	2001	143
Assessment of potential drug–drug interactions with a prescription claims database Daniel C. Malone, David Hutchins, Heather Haupert, American Journal of Health-System Pharmacy	2005	118
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Thomas L. Vaughan, Diana C. Farrow, Philip D. Hansten, PubMed AsthmaGastric AdenocarcinomasEsophagusEsophageal CancerGastric Cardia	1998	117
Recommendations for selecting drug–drug interactions for clinical decision support Hugh H. Tilson, Lisa E. Hines, Gerald K. McEvoy, American Journal of Health-System Pharmacy	2016	73

Page 1